Pain
-
Spinal cord stimulation reduces pain of critical ischaemia in patients with severe inoperable coronary artery and peripheral vascular disease by increasing microvascular flow. Patients with cardiac pacemaker may be denied a spinal cord stimulator (SCS) implant because of the risk of compromising pacemaker function by inhibition or reversion to asynchronous noise-pacing mode. We describe the management of a patient with an SCS implant for lower limb ischaemia who required a pacemaker. We suggest that with modern pacemakers it is safe to implant a spinal cord stimulator simultaneously with a pacemaker provided adequate precautions are taken to prevent interdevice interference.
-
Psychophysical methods were used to investigate pain in human subjects elicited by controlled freezing of the skin using a novel vortex thermode. When cooling stimuli delivered with a small thermode (7 mm diameter) exceeded the normal cold pain threshold into the sub-zero temperature range (-5 to -11 degrees C), all subjects reported an intense, sharp stinging pain sensation which occurred suddenly and was readily differentiated from normal cold pain. The onset of this stinging 'freezing' pain was closely correlated with a sudden increase in skin temperature beneath the thermode of 4.77+/-0.86 degrees C (+/-SD) associated with the phase transition of supercooled water to ice. ⋯ The changes in thermal sensitivity were not accompanied by consistent changes in mechanical sensitivity. These results indicate that a characteristic sharp, stinging pain is reliably evoked abruptly at the phase transition of supercooled skin water to ice The ensuing brief decrease in cold pain threshold with burning quality, coupled with decreased sensitivity to cold, are speculated to reflect a central disinhibition of C-fiber nociceptor input due to reduced cold fiber activity. These effects may be relevant to frostbite, and distinguish themselves from the more pronounced thermal and mechanical hyperalgesia seen following intense freeze lesion of the skin.
-
Gabapentin is an effective option for the treatment of neuropathic pain syndromes because of its efficacy and favorable side-effect profile. A case is presented of a 58 year old man who developed a painful polyneuropathy while being treated with gabapentin.